Immunic (IMUX) announced that it will effect a reverse stock split of its outstanding shares of common stock, effective as of 12:01 a.m. Eastern Time on April 27. Immunic’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol “IMUX” and will begin trading on a reverse stock split-adjusted basis at the opening of the Nasdaq Capital Market on April 27. The new CUSIP number for the split-adjusted common stock will be 4525EP200.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMUX:
- Immunic Buy Rating: Vidofludimus Calcium’s Differentiated Efficacy and Safety Profile vs. BTK Inhibitors in Relapsing MS
- Okta, Immunic, FirstEnergy, ADC, GNL Trending With Analysts
- Immunic initiated with a Buy at Stifel
- Immunic downgraded to Hold from Buy at D. Boral Capital
- Immunic Sets 1-for-10 Reverse Stock Split Plan